Fiorenzo Paronetto
Overview
Explore the profile of Fiorenzo Paronetto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
276
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lieber C, Weiss D, Paronetto F
Alcohol Clin Exp Res
. 2008 Apr;
32(6):1031-9.
PMID: 18422837
Background: Our aim was to identify markers predictive of fibrosis in alcoholic liver disease (ALD). Percutaneous liver biopsy is the recommended standard for histologic assessment of liver fibrosis. Seven serum...
2.
Lieber C, Weiss D, Morgan T, Paronetto F
Am J Gastroenterol
. 2006 Jul;
101(7):1500-8.
PMID: 16863553
Objective: Aspartate aminotransferase (AST) to platelet ratio index (APRI) has been proposed as an easily determined and accurate noninvasive marker of liver fibrosis in chronic hepatitis C. To validate APRI...
3.
Brau N, Salvatore M, Rios-Bedoya C, Fernandez-Carbia A, Paronetto F, Rodriguez-Orengo J, et al.
J Hepatol
. 2005 Sep;
44(1):47-55.
PMID: 16182404
Background/aims: HIV/HCV-coinfected patients reportedly have a faster fibrosis progression rate (FPR) than HCV-monoinfected patients. This study examined whether HIV suppression through highly active antiretroviral therapy (HAART) attenuates this accelerated fibrosis...
4.
Lieber C, Weiss D, Groszmann R, Paronetto F, Schenker S
Alcohol Clin Exp Res
. 2003 Nov;
27(11):1765-72.
PMID: 14634492
Background: Polyenylphosphatidylcholine (PPC) has been shown to prevent alcoholic cirrhosis in animals. Our aims were to determine the effectiveness of PPC in preventing or reversing liver fibrosis in heavy drinkers...
5.
Lieber C, Weiss D, Groszmann R, Paronetto F, Schenker S
Alcohol Clin Exp Res
. 2003 Nov;
27(11):1757-64.
PMID: 14634491
Background: This multicenter prospective, randomized, double-blind placebo-controlled trial was designed to evaluate the effectiveness of polyenylphosphatidylcholine against the progression of liver fibrosis toward cirrhosis in alcoholics. Seven hundred eighty-nine alcoholics...
6.
Ren C, Paronetto F, Mak K, Leo M, Lieber C
J Hepatol
. 2003 May;
38(6):770-5.
PMID: 12763370
Background/aims: Not all alcoholic patients develop severe liver disease with fibrosis progressing to cirrhosis. It is of practical importance to determine whether some markers can predict progression of liver fibrosis....
7.
Brau N, Bini E, Shahidi A, Aytaman A, Xiao P, Stancic S, et al.
Am J Gastroenterol
. 2002 Aug;
97(8):2071-8.
PMID: 12190179
Objectives: The aims of this study were to determine the prevalence of hepatitis C virus (HCV) infection and its risk factors, as well as the prevalence of coinfection with HIV...